Physician profile
Prem Parmar
NPI 1699747949
$18,292.28
in general payments reported to CMS, 2019-2025
15 companies · $2,990 in 2025
The $2,990 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,419 · 2020: $3,217 · 2021: $2,859 · 2022: $4,904 · 2023: $698 · 2024: $1,204 · 2025: $2,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,123 · Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,122.74 |
| Food and Beverage | $1,770.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $10,468.21 | 2020-2025 | |
| Smith+Nephew, INC. | $2,241.00 | 2019-2022 | |
| Arthrex, INC. | $2,152.00 | 2020-2025 | |
| Anika Therapeutics, INC. | $1,305.06 | 2021-2023 | Tactoset |
| Linvatec Corporation | $1,128.15 | 2019-2025 | Biobrace 23mm, Anchor, Y-Knot |
| Kinamed, INC. | $341.48 | 2023 | |
| Stryker Corporation | $296.04 | 2021 | |
| Zimmer Biomet Holdings, INC. | $118.20 | 2019 | |
| Avanos Medical | $112.63 | 2024 | On-Q* Pump and Accessories, Pnb and Accessories |
| Encore Medical, Lp | $41.62 | 2025 | Djo Surgical |
| Next Science LLC | $26.81 | 2021 | |
| Ermi LLC | $22.37 | 2019 | |
| Vericel Corporation | $17.81 | 2021 | |
| Ibsa Pharma INC. | $13.92 | 2023 | Tirosint, Licart |
| Dynasplint Systems INC. | $6.98 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Parmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.